349 related articles for article (PubMed ID: 15378510)
1. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
[TBL] [Abstract][Full Text] [Related]
2. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
3. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine.
Molina-Holgado E; Dewar KM; Descarries L; Reader TA
J Pharmacol Exp Ther; 1994 Aug; 270(2):713-21. PubMed ID: 8071864
[TBL] [Abstract][Full Text] [Related]
4. Alterations in serotonin signalling are involved in the hyperactivity of Pitx3-deficient mice.
Smits SM; Noorlander CW; Kas MJ; Ramakers GM; Smidt MP
Eur J Neurosci; 2008 Jan; 27(2):388-95. PubMed ID: 18215235
[TBL] [Abstract][Full Text] [Related]
5. Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned rats.
Scholtissen B; Deumens R; Leentjens AF; Schmitz C; Blokland A; Steinbusch HW; Prickaerts J
Pharmacol Biochem Behav; 2006 Feb; 83(2):175-85. PubMed ID: 16504275
[TBL] [Abstract][Full Text] [Related]
6. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
[TBL] [Abstract][Full Text] [Related]
7. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
8. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
9. Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study.
Balcioglu A; Zhang K; Tarazi FI
Neuroscience; 2003; 119(4):1045-53. PubMed ID: 12831863
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
11. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice.
Esaki T; Cook M; Shimoji K; Murphy DL; Sokoloff L; Holmes A
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5582-7. PubMed ID: 15809439
[TBL] [Abstract][Full Text] [Related]
12. Proposed animal model of attention deficit hyperactivity disorder.
Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
14. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
15. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
16. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
Brus R; Kostrzewa RM; Perry KW; Fuller RW
J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
Sawynok J; Reid A
J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
Nowak P; Bortel A; Dabrowska J; Oswiecimska J; Drosik M; Kwiecinski A; Opara J; Kostrzewa RM; Brus R
Neurotox Res; 2007 Feb; 11(2):131-44. PubMed ID: 17449455
[TBL] [Abstract][Full Text] [Related]
19. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
